Pharmaceutical Product Development Stock Soars (PPDI)
NEW YORK (TheStreet) -- Shares of Pharmaceutical Product Development (Nasdaq:PPDI) have taken a tremendous swing upward. The stock is trading at $32.22 as of 10:06 a.m. ET, 25.6% above Friday's closing price of $25.66. Volume is at 5.7 million, 3.7 times the daily average of 1.5 million. Pharmaceutical Product Development has a market cap of $3 billion and is part of the health care sector and health services industry. Shares are down 5.5% year to date as of the close of trading on Friday. Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery, development, and lifecycle management services. It operates in two segments, Clinical Development Services and Laboratory Services. The company has a P/E ratio of 41.6, above the average health services industry P/E ratio of 18.2 and above the S&P 500 P/E ratio of 17.7. TheStreet Ratings rates Pharmaceutical Product Development as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and compelling growth in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Pharmaceutical Product Development Ratings Report. See our top % gaining stocks list for other stocks that are soaring today, or get investment ideas from our investment research center. Interested in other stocks that are soaring? Get free SMS text alerts sent to you when the action happens by texting SOAR to 95370 or select from multiple alert options.
Latest Headlines about PPDI
-
7 Stocks Hitting New 52-Week Highs
01:32PM 10/17/11
-
PPDI Inks $3.9 Billion PE Buyout (Update 1)
03:15PM 10/03/11
-
10 Stocks to Watch: URBN, PPDI
08:56AM 08/16/11
-
Pharmaceutical Product Development CEO Discusses Q2 2011 Results - Earnings Call Transcript
03:04PM 07/27/11
-
Pharmaceutical Product Development - Upgrades & Downgrades
09:56AM 04/07/11
-
PPDI Shares Climb On Analyst Upgrade
01:20PM 12/14/09
-
PPD Buys BioDuro For $77M In China Expansion
09:59AM 11/30/09
Latest from TheStreet Wire
-
FMC Stock Hits New 52-Week High (FMC)
12:05PM 05/23/13
-
Dow Today: Home Depot (HD) Lower
12:00PM 05/23/13
-
4 Buy-Rated Dividend Stocks: AI, ARI, SBR, CLCT
11:30AM 05/23/13
-
3 Buy-Rated Dividend Stocks: NRP, PVD, BPT
11:30AM 05/23/13
-
5 Hold-Rated Dividend Stocks: CNSL, MCEP, LRE, NTRI, MEMP
11:30AM 05/23/13
-
3 Sell-Rated Dividend Stocks: VLCCF, STB, VOC
11:30AM 05/23/13
-
4 Hold-Rated Dividend Stocks: RGP, CWH, CPWR, RGC
11:30AM 05/23/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
